Your browser doesn't support javascript.
loading
Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderly.
Ferreira, Isabella A T M; Lee, Colin Y C; Foster, William S; Abdullahi, Adam; Dratva, Lisa M; Tuong, Zewen Kelvin; Stewart, Benjamin J; Ferdinand, John R; Guillaume, Stephane M; Potts, Martin O P; Perera, Marianne; Krishna, Benjamin A; Peñalver, Ana; Cabantous, Mia; Kemp, Steven A; Ceron-Gutierrez, Lourdes; Ebrahimi, Soraya; Lyons, Paul; Smith, Kenneth G C; Bradley, John; Collier, Dami A; McCoy, Laura E; van der Klaauw, Agatha; Thaventhiran, James E D; Farooqi, I Sadaf; Teichmann, Sarah A; MacAry, Paul A; Doffinger, Rainer; Wills, Mark R; Linterman, Michelle A; Clatworthy, Menna R; Gupta, Ravindra K.
Affiliation
  • Ferreira IATM; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Lee CYC; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, UK; Cellular Genetics, Wellcome Sanger Institute, Cambridge, UK.
  • Foster WS; Immunology Programme, Babraham Institute, Babraham Research Campus, Cambridge, UK.
  • Abdullahi A; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Dratva LM; Cellular Genetics, Wellcome Sanger Institute, Cambridge, UK.
  • Tuong ZK; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, UK; Cellular Genetics, Wellcome Sanger Institute, Cambridge, UK.
  • Stewart BJ; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, UK; Cellular Genetics, Wellcome Sanger Institute, Cambridge, UK.
  • Ferdinand JR; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, UK.
  • Guillaume SM; Immunology Programme, Babraham Institute, Babraham Research Campus, Cambridge, UK.
  • Potts MOP; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Perera M; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Krishna BA; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Peñalver A; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, UK.
  • Cabantous M; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, UK.
  • Kemp SA; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Ceron-Gutierrez L; Department of Clinical Biochemistry and Immunology, Cambridge University Hospital NHS Trust, Cambridge, UK.
  • Ebrahimi S; Department of Clinical Biochemistry and Immunology, Cambridge University Hospital NHS Trust, Cambridge, UK.
  • Lyons P; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Smith KGC; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Bradley J; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Collier DA; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK.
  • McCoy LE; Division of Infection and Immunity, UCL, London, UK.
  • van der Klaauw A; University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Wellcome-Medical Research Council (MRC) Institute of Metabolic Science, Cambridge, UK.
  • Thaventhiran JED; MRC Toxicology Unit, University of Cambridge, Cambridge, UK.
  • Farooqi IS; University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Wellcome-Medical Research Council (MRC) Institute of Metabolic Science, Cambridge, UK.
  • Teichmann SA; Cellular Genetics, Wellcome Sanger Institute, Cambridge, UK.
  • MacAry PA; National University of Singapore, Singapore, Singapore.
  • Doffinger R; Department of Clinical Biochemistry and Immunology, Cambridge University Hospital NHS Trust, Cambridge, UK.
  • Wills MR; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Linterman MA; Immunology Programme, Babraham Institute, Babraham Research Campus, Cambridge, UK. Electronic address: michelle.linterman@babraham.ac.uk.
  • Clatworthy MR; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge,
  • Gupta RK; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK. Electronic address: rkg20@cam.ac.uk.
Cell Rep ; 42(8): 112991, 2023 08 29.
Article in En | MEDLINE | ID: mdl-37590132
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Limits: Aged / Humans Language: En Journal: Cell Rep Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Limits: Aged / Humans Language: En Journal: Cell Rep Year: 2023 Document type: Article Affiliation country: Country of publication: